Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
BMJ (Clinical Research Ed.)
|
August 19, 2006
Outpatient treatment of falciparum malaria is possible
Mark Melzer
Evidence-Based Medicine
|
December 21, 2010
An automated molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) is sensitive and can be carried out in less than 2 h
Mark Melzer
The Journal of Infection
|
June 19, 2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli
Mark Melzer, Irene Petersen
The Lancet. Infectious Diseases
|
January 28, 2012
Is Escherichia coli bacteraemia preventable?
Mark Melzer, Cathy Welch
The Journal of Infection
|
May 15, 2012
A re-audit of outcomes in patients with ESBL producing Escherichia coli bacteraemia
Mark Melzer, Irene Petersen
Postgraduate Medical Journal
|
March 23, 2013
Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections
Mark Melzer, Catherine Welch
Postgraduate Medical Journal
|
February 22, 2018
Strategy to reduce <i>E. coli</i> bacteraemia based on cohort data from a London teaching hospital
Desmond Hsu, Mark Melzer
Jac-Antimicrobial Resistance
|
May 31, 2024
Clinical outcomes in OPAT patients treated with ceftriaxone 4 g and ceftazidime 6 g extended interval dosing regimens
David Wareham, Mark Melzer
The Journal of Infection
|
August 27, 2009
The case for outpatient treatment of Plasmodium falciparum malaria in a selected UK immigrant population
Mark Melzer, Sandra Lacey, Greta Rait
Postgraduate Medical Journal
|
November 9, 2016
The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment
Mark Melzer, Liana Macpherson, Catherine Welch
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
BMJ (Clinical Research Ed.)
|
August 19, 2006
Outpatient treatment of falciparum malaria is possible
Mark Melzer
Evidence-Based Medicine
|
December 21, 2010
An automated molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) is sensitive and can be carried out in less than 2 h
Mark Melzer
The Journal of Infection
|
June 19, 2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli
Mark Melzer, Irene Petersen
The Lancet. Infectious Diseases
|
January 28, 2012
Is Escherichia coli bacteraemia preventable?
Mark Melzer, Cathy Welch
The Journal of Infection
|
May 15, 2012
A re-audit of outcomes in patients with ESBL producing Escherichia coli bacteraemia
Mark Melzer, Irene Petersen
Postgraduate Medical Journal
|
March 23, 2013
Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections
Mark Melzer, Catherine Welch
Postgraduate Medical Journal
|
February 22, 2018
Strategy to reduce <i>E. coli</i> bacteraemia based on cohort data from a London teaching hospital
Desmond Hsu, Mark Melzer
Jac-Antimicrobial Resistance
|
May 31, 2024
Clinical outcomes in OPAT patients treated with ceftriaxone 4 g and ceftazidime 6 g extended interval dosing regimens
David Wareham, Mark Melzer
The Journal of Infection
|
August 27, 2009
The case for outpatient treatment of Plasmodium falciparum malaria in a selected UK immigrant population
Mark Melzer, Sandra Lacey, Greta Rait
Postgraduate Medical Journal
|
November 9, 2016
The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment
Mark Melzer, Liana Macpherson, Catherine Welch
Page
of 4